A decrease in TFF1 protein was observed (Figure 1C–E) in parallel with the reduction in the TFF1 RNA level (Figure 1A) in both CRC cell types, demonstrating that TFF1 levels are reduced by L1 in human CRC cells where different mutations in the Wnt/β-catenin pathway activate β-catenin/TCF signaling. The gene discussed is TFF1; the disease is colorectal carcinoma.